Search research articles
Contact Us
Filters
Showing results (91-100 of 132) with videos related to
Page
of 14
Sort By:
Annals of Surgical Oncology
|
November 9, 2011
Patterns of care, prognosis, and survival in patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib
Antoine Italiano, Angela Cioffi, Paola Coco, et al.
International Journal of Cancer
|
October 6, 2021
Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma Group
Pascaline Boudou-Rouquette, Elodie Martin, Emmanuelle Kempf, et al.
Cancer
|
July 7, 2022
Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and Taiwan
Tom Wei-Wu Chen, Ruru Chun-Ju Chiang, Alex Le Cesne, et al.
The New England Journal of Medicine
|
September 4, 2024
Doxorubicin-Trabectedin with Trabectedin Maintenance in Leiomyosarcoma
Patricia Pautier, Antoine Italiano, Sophie Piperno-Neumann, et al.
Annals of Surgical Oncology
|
November 28, 2019
Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study
Mathias Neron, Christophe Sajous, Simon Thezenas, et al.
Oncotarget
|
October 24, 2018
Surrogate endpoints in advanced sarcoma trials: a meta-analysis
Marion Savina, Saskia Litière, Antoine Italiano, et al.
The Lancet. Oncology
|
March 22, 2015
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial
Patricia Pautier, Anne Floquet, Christine Chevreau, et al.
British Journal of Cancer
|
November 2, 2023
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study
Florence Duffaud, Jean-Yves Blay, Axel Le Cesne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 3, 2015
Trabectedin in patients with advanced soft tissue sarcoma: a retrospective national analysis of the French Sarcoma Group
Axel Le Cesne, Isabelle Ray-Coquard, Florence Duffaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2012
Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era
Philippe A Cassier, Elena Fumagalli, Piotr Rutkowski, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 132) with videos related to
Sort By:
Page
of 14
Annals of Surgical Oncology
|
November 9, 2011
Patterns of care, prognosis, and survival in patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib
Antoine Italiano, Angela Cioffi, Paola Coco, et al.
International Journal of Cancer
|
October 6, 2021
Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma Group
Pascaline Boudou-Rouquette, Elodie Martin, Emmanuelle Kempf, et al.
Cancer
|
July 7, 2022
Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and Taiwan
Tom Wei-Wu Chen, Ruru Chun-Ju Chiang, Alex Le Cesne, et al.
The New England Journal of Medicine
|
September 4, 2024
Doxorubicin-Trabectedin with Trabectedin Maintenance in Leiomyosarcoma
Patricia Pautier, Antoine Italiano, Sophie Piperno-Neumann, et al.
Annals of Surgical Oncology
|
November 28, 2019
Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study
Mathias Neron, Christophe Sajous, Simon Thezenas, et al.
Oncotarget
|
October 24, 2018
Surrogate endpoints in advanced sarcoma trials: a meta-analysis
Marion Savina, Saskia Litière, Antoine Italiano, et al.
The Lancet. Oncology
|
March 22, 2015
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial
Patricia Pautier, Anne Floquet, Christine Chevreau, et al.
British Journal of Cancer
|
November 2, 2023
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study
Florence Duffaud, Jean-Yves Blay, Axel Le Cesne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 3, 2015
Trabectedin in patients with advanced soft tissue sarcoma: a retrospective national analysis of the French Sarcoma Group
Axel Le Cesne, Isabelle Ray-Coquard, Florence Duffaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2012
Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era
Philippe A Cassier, Elena Fumagalli, Piotr Rutkowski, et al.
Page
of 14